Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen’s Sale of BioReliance Topped Most-Read GenomeWeb News Stories Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Feb. 16.
 
1. Invitrogen to Sell BioReliance for $210M; Posts Weak Revenue Gain and $100M Loss in Q4 (from Feb. 14)
 
2. House Bill Seeks to Prohibit 'All' New Human Genome Patenting (from Feb. 16)
 
3. Qiagen Licenses RT-PCR IP From Roche, Ortho Clinical Diagnostics (from Feb. 15)
 
4. Illumina Makes Brass Changes; ABI's SDS Manager Joins Gen-Probe as COO; Former Affy CFO Joins Entelos Board; and Others (from Feb. 16)
 
5. Illumina to Offer $325M in Convertible Notes; Will Use $200M to Repurchase Shares (from Feb. 12)
The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.